EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, cilt.22, sa.6, ss.463-465, 2001 (SCI-Expanded)
Purpose: To investigate the efficacy and safety of single-dose filgrastim administered 24 hours prior to chemotherapy in the prevention of topotecan-related myeloid suppression.